AMERICAN SHARED HOSPITAL SERVICES Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits of -$60.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement › Other Income
us-gaap:IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits · last filed 2019-11-07
- AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in deferred revenue and customer advances and deposits for the quarter ending 2019-09-30 was -$12.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in deferred revenue and customer advances and deposits for the quarter ending 2019-06-30 was -$33.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in deferred revenue and customer advances and deposits for the quarter ending 2019-03-31 was -$15.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase (decrease) in deferred revenue and customer advances and deposits for the quarter ending 2018-09-30 was -$35.00K.
| Period end | Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits 3 month | Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits 6 month | Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits 9 month |
|---|---|---|---|
| 2019-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$45.00K derived: sum of 2 quarters · filed 2019-11-07 | -$60.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$48.00K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$15.00K 10-Q · filed 2019-05-13 | ||
| 2018-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$53.00K derived: sum of 2 quarters · filed 2019-11-07 | -$93.00K 10-Q · filed 2019-11-07 |
| 2018-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$58.00K 10-Q · filed 2019-08-13 | |
| 2018-03-31 | -$40.00K 10-Q · filed 2019-05-13 | ||
| 2017-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$53.00K derived: sum of 2 quarters · filed 2018-11-09 | -$84.00K 10-Q · filed 2018-11-09 |
| 2017-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$57.00K 10-Q · filed 2018-08-09 | |
| 2017-03-31 | -$31.00K 10-Q · filed 2018-05-10 | ||
| 2016-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$108.00K derived: sum of 2 quarters · filed 2017-08-10 | -$186.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$108.00K 10-Q · filed 2017-08-10 | |
| 2016-03-31 | -$78.00K 10-Q · filed 2017-05-15 | ||
| 2015-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$60.00K derived: sum of 2 quarters · filed 2016-11-10 | -$43.00K 10-Q · filed 2016-11-10 |
| 2015-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$13.00K 10-Q · filed 2016-08-11 | |
| 2015-03-31 | $17.00K 10-Q · filed 2016-05-12 | ||
| 2014-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$25.00K derived: sum of 2 quarters · filed 2015-11-12 | -$37.00K 10-Q · filed 2015-11-12 |
| 2014-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$25.00K 10-Q · filed 2015-08-19 | |
| 2014-03-31 | -$12.00K 10-Q · filed 2015-05-14 | ||
| 2013-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$25.00K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$12.00K 10-Q · filed 2014-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |